PURE BIOSCIENCE by PURE Bioscience Earnings & Forecasts

SPY—QQQ—BTC/USD—DIA—GLD—TLT—

Premium

PURE BIOSCIENCE by PURE Bioscience

PUREOTCQB

Trade with Public

$0.0752

0.0071210.46%

Last update: Oct 16, 3:58 PM

Overview NewsEarnings ForecastFinancials Sentiment Ownership Compare

PURE BIOSCIENCE by PURE Bioscience Earnings & Forecasts

PURE BIOSCIENCE by PURE Bioscience (PURE) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

PURE BIOSCIENCE by PURE Bioscience Guidance

Recent Earnings Results

Metric	Q3 '26	Q2 '26	Q1 '26	Q4 '25
Earnings Per Share (Non-GAAP)
Estimate	—	—	—	—
Actual	$-0.01	$-0.01	$0.00	$0.00
Surprise	—	—	—	—
Revenue
Estimate	—	—	—	—
Actual	$506000	$443000	$707000	$764000
Surprise	—	—	—	—

Earnings & Guidance News

PRO
PURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $506.000K Up From $491.000K YoY

PURE Bioscience (OTC:PURE) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year. The company reported $506.000 thousand in sales this quarter. This is a 3.05 percent increase

Benzinga Newsdesk

PRO
PURE Bioscience Q2 EPS $(0.01), Same YoY, Sales $443.000K Up From $391.000K YoY

PURE Bioscience (OTC:PURE) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year. The company reported $443.000 thousand in sales this quarter. This is a 13.30 percent increase

Benzinga Newsdesk

PRO
PURE Bioscience Q1 Sales $707.000K Up From $556.000K YoY

PURE Bioscience (OTC:PURE) reported $707.000 thousand in sales this quarter. This is a 27.16 percent increase over sales of $556.000 thousand the same period last year.

Benzinga Newsdesk

PRO
PURE Bioscience Q4 Sales $764.000K Up From $474.000K YoY

PURE Bioscience (OTC:PURE) reported $764.000 thousand in sales this quarter. This is a 61.18 percent increase over sales of $474.000 thousand the same period last year.

Benzinga Newsdesk

PRO
PURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $491.00K Up From $441.00K YoY

PURE Bioscience (OTC:PURE) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year. The company reported $491.00 thousand in sales this quarter. This is a 11.34 percent increase

Benzinga Newsdesk

PRO
PURE Bioscience Q2 2025 EPS ($0.01) In-Line YoY; Revenue $391K Up From $325K YoY.

Benzinga Newsdesk

PURE BIOSCIENCE by PURE Bioscience

PURE BIOSCIENCE by PURE Bioscience Earnings & Forecasts

PURE BIOSCIENCE by PURE Bioscience Guidance

Recent Earnings Results

Earnings & Guidance News

PROPURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $506.000K Up From $491.000K YoY

PROPURE Bioscience Q2 EPS $(0.01), Same YoY, Sales $443.000K Up From $391.000K YoY

PROPURE Bioscience Q1 Sales $707.000K Up From $556.000K YoY

PROPURE Bioscience Q4 Sales $764.000K Up From $474.000K YoY

PROPURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $491.00K Up From $441.00K YoY

PROPURE Bioscience Q2 2025 EPS ($0.01) In-Line YoY; Revenue $391K Up From $325K YoY.

PURE BIOSCIENCE by PURE Bioscience Earnings & Forecasts

PURE BIOSCIENCE by PURE Bioscience Guidance

Recent Earnings Results

Earnings & Guidance News

PROPURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $506.000K Up From $491.000K YoY

PROPURE Bioscience Q2 EPS $(0.01), Same YoY, Sales $443.000K Up From $391.000K YoY

PROPURE Bioscience Q1 Sales $707.000K Up From $556.000K YoY

PROPURE Bioscience Q4 Sales $764.000K Up From $474.000K YoY

PROPURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $491.00K Up From $441.00K YoY

PROPURE Bioscience Q2 2025 EPS ($0.01) In-Line YoY; Revenue $391K Up From $325K YoY.

PRO
PURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $506.000K Up From $491.000K YoY

PRO
PURE Bioscience Q2 EPS $(0.01), Same YoY, Sales $443.000K Up From $391.000K YoY

PRO
PURE Bioscience Q1 Sales $707.000K Up From $556.000K YoY

PRO
PURE Bioscience Q4 Sales $764.000K Up From $474.000K YoY

PRO
PURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $491.00K Up From $441.00K YoY

PRO
PURE Bioscience Q2 2025 EPS ($0.01) In-Line YoY; Revenue $391K Up From $325K YoY.

PRO
PURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $506.000K Up From $491.000K YoY

PRO
PURE Bioscience Q2 EPS $(0.01), Same YoY, Sales $443.000K Up From $391.000K YoY

PRO
PURE Bioscience Q1 Sales $707.000K Up From $556.000K YoY

PRO
PURE Bioscience Q4 Sales $764.000K Up From $474.000K YoY

PRO
PURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $491.00K Up From $441.00K YoY

PRO
PURE Bioscience Q2 2025 EPS ($0.01) In-Line YoY; Revenue $391K Up From $325K YoY.